Skip to content

Eli Lilly forays into dermatological space with launch of psoriasis drug

The company has launched Copellor in the market after getting approval from the Drug Controller General of India (DCGI).

Read More

​ The company has launched Copellor in the market after getting approval from the Drug Controller General of India (DCGI). The company has launched Copellor in the market after getting approval from the Drug Controller General of India (DCGI).  Moneycontrol Latest News Read More  

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish